AYTU BIOPHARMA, INC Proceeds from (Repayments of) Short-term Debt
AYTU BIOPHARMA, INC (AYTU) reported Proceeds from (Repayments of) Short-term Debt of $6.59 million for the 9-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfShortTermDebt · last filed 2023-05-11
- AYTU BIOPHARMA, INC proceeds from (repayments of) short-term debt for the quarter ending 2023-03-31 was $2.97M.
- AYTU BIOPHARMA, INC proceeds from (repayments of) short-term debt for the quarter ending 2022-03-31 was -$3.77M.
| Period end | Proceeds from (Repayments of) Short-term Debt 3 month | Proceeds from (Repayments of) Short-term Debt 6 month | Proceeds from (Repayments of) Short-term Debt 9 month |
|---|---|---|---|
| 2023-03-31 | $2.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | $6.59M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $3.62M 10-Q · filed 2023-02-21 | ||
| 2022-03-31 | -$3.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | -$4.55M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | -$775.00K 10-Q · filed 2023-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |